FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

JOURNAL ARTICLE published 20 December 2018 in New England Journal of Medicine

Research funded by Canadian Cancer Society (Program Grant #704970) | Institut National du Cancer (Clinical Research Hospital Program grant (PHRC11-0)

Authors: Thierry Conroy | Pascal Hammel | Mohamed Hebbar | Meher Ben Abdelghani | Alice C. Wei | Jean-Luc Raoul | Laurence Choné | Eric Francois | Pascal Artru | James J. Biagi | Thierry Lecomte | Eric Assenat | Roger Faroux | Marc Ychou | Julien Volet | Alain Sauvanet | Gilles Breysacher | Frédéric Di Fiore | Christine Cripps | Petr Kavan | Patrick Texereau | Karine Bouhier-Leporrier | Faiza Khemissa-Akouz | Jean-Louis Legoux | Béata Juzyna | Sophie Gourgou | Christopher J. O’Callaghan | Claire Jouffroy-Zeller | Patrick Rat | David Malka | Florence Castan | Jean-Baptiste Bachet